- Home
- NVX vs THRD Comparison
NVX vs THRD Comparison
Compare NVX & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVX
- THRD
- Stock Information
- Founded
- NVX 2012
- THRD 2019
- Country
- NVX Australia
- THRD United States
- Employees
- NVX N/A
- THRD N/A
- Industry
- NVX Industrial Machinery/Components
- THRD Biotechnology: Pharmaceutical Preparations
- Sector
- NVX Miscellaneous
- THRD Health Care
- Exchange
- NVX Nasdaq
- THRD Nasdaq
- Market Cap
- NVX 169.3M
- THRD 164.2M
- IPO Year
- NVX N/A
- THRD 2022
- Fundamental
- Price
- NVX $1.23
- THRD $5.15
- Analyst Decision
- NVX Strong Buy
- THRD Hold
- Analyst Count
- NVX 1
- THRD 3
- Target Price
- NVX $4.00
- THRD $5.00
- AVG Volume (30 Days)
- NVX 68.4K
- THRD 1.1M
- Earning Date
- NVX 01-01-0001
- THRD 05-19-2025
- Dividend Yield
- NVX N/A
- THRD N/A
- EPS Growth
- NVX N/A
- THRD N/A
- EPS
- NVX N/A
- THRD N/A
- Revenue
- NVX $5,854,424.00
- THRD N/A
- Revenue This Year
- NVX $66.66
- THRD N/A
- Revenue Next Year
- NVX $2,366.64
- THRD N/A
- P/E Ratio
- NVX N/A
- THRD N/A
- Revenue Growth
- NVX N/A
- THRD N/A
- 52 Week Low
- NVX $0.81
- THRD $3.18
- 52 Week High
- NVX $2.73
- THRD $16.94
- Technical
- Relative Strength Index (RSI)
- NVX 58.22
- THRD 76.77
- Support Level
- NVX $1.09
- THRD $5.13
- Resistance Level
- NVX $1.20
- THRD $5.25
- Average True Range (ATR)
- NVX 0.07
- THRD 0.05
- MACD
- NVX 0.01
- THRD -0.03
- Stochastic Oscillator
- NVX 92.04
- THRD 41.18
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.